ArticleAnnals of surgery2025
Age Matters: What Affects the Cumulative Lifespan of a Transplanted Liver?
Article in Annals of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 13 citations in OpenAlex.
- Interactions Between Donor and Recipient age in Liver Transplantation: Implications for Donor and Recipient Matching.Transplantation · 2026Article
- Tailoring Liver Transplant Decisions: How Donor-Recipient Age Matching Influences Outcomes.Clinical transplantation · 2026Article
- Elderly Ages in Liver Transplantation: Are Older Donors Really Higher Risk?Transplantation direct · 2025Article
- Response to Comment on: Age Matters: What Affects the Cumulative Lifespan of a Transplanted Liver? Continued Yet Cautious Expansion of Donor Age in US-Based Liver Transplantation.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2024Article
- Comment on "Age Matters: What Affects the Cumulative Lifespan of a Transplanted Liver?"Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2024Article
- Response to Comment on: Age Matters: What Affects the Cumulative Lifespan of a Transplanted Liver?Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2024Article
- Comment on: Age Matters. What Affects the Cumulative Lifespan of a Transplanted Liver?Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2024Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
8 authors at 6 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess factors affecting the cumulative lifespan of a transplanted liver.
backgroundLiver aging is different from other solid organs. It is unknown how old a liver can actually get after liver transplantation.
methodsDeceased donor liver transplants from 1988 to 2021 were queried from the United States UNOS registry. Cumulative liver age was calculated as donor age + recipient graft survival.
resultsIn total, 184,515 livers were included. Most were donation after brain death donors (n = 175,343). The percentage of livers achieving >70, 80, 90, and 100 years cumulative age was 7.8% (n = 14,392), 1.9% (n = 3576), 0.3% (n = 528), and 0.01% (n = 21), respectively. The youngest donor age contributing to a cumulative liver age >90 years was 59 years, with posttransplant survival of 34 years. In pediatric recipients, 736 (4.4%) and 282 livers (1.7%) survived >50 and 60 years overall, respectively. Transplanted livers achieved cumulative age >90 years in 2.86 per 1000 and >100 years in 0.1 per 1000. The U.S. population at large has a cumulative "liver age" >90 years in 5.35 per 1000 persons, and >100 years in 0.2 per 1000. Livers aged >60 years at transplant experienced both improved cumulative survival ( P < 0.0001) and interestingly improved survival after transplantation ( P < 0.0001). Recipient warm ischemia time of >30 minutes was most predictive of reduced cumulative liver survival overall (n = 184,515, hazard ratio = 1.126, P < 0.001) and excluding patients with mortality in the first 6 months (n = 151,884, hazard ratio = 0.973, P < 0.001).
conclusionsIn summary, transplanted livers frequently get as old as those in the average population despite ischemic-reperfusion-injury and immunosuppression. The presented results justify using older donor livers regardless of donation type, even in sicker recipients with limited options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.